Clinical Research Directory
Browse clinical research sites, groups, and studies.
Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
Sponsor: University of Edinburgh
Summary
The ORACLE study is an observational cohort study designed to explore the feasibility of providing an assessment of chest pain for patients with suspected angina within one working day of referral to specialist services. The primary objective is to determine the feasibility of delivering an objective assessment of risk for participants who have been referred by their primary care provider to the rapid access chest pain clinic with possible angina in a community setting using point of care and patient facing technologies within one working day of referral. Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms. Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured by point of care high sensitivity cardiac troponin assays as well as a core lab assay. The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events.
Official title: ORACLE: Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
Key Details
Gender
All
Age Range
30 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-07-04
Completion Date
2026-12-31
Last Updated
2026-04-07
Healthy Volunteers
No
Conditions
Interventions
The assessment of patients with possible angina using the ORACLE pathway
Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms. Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured. The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events.
Locations (1)
NHS Lothian
Edinburgh, United Kingdom